MDL | MFCD03723253 |
---|---|
Molecular Weight | 338.40 |
Molecular Formula | C23H18N2O |
SMILES | OC1=CC=C(C(C2=CNC3=C2C=CC=C3)C4=CNC5=C4C=CC=C5)C=C1 |
Nuclear receptor 4A1 (NR4A1) [1]
DIM-C-pPhOH (7.5-20 μM; 24 hours; ACHN and 786-O cells) treatment significantly decreases cell proliferation
[1]
.
DIM-C-pPhOH (20 μM; 24 hours; ACHN and 786-O cells) treatment induces Annexin V staining in ACHN and 786-O cells, confirming that DIM-C-pPhOH induce apoptosis, and also induces cleavage of caspases 7 and 8
[1]
.
DIM-C-pPhOH (15-20 μM; 24 hours; ACHN and 786-O cells) treatment inhibits NR4A1-regulated expression of survivin, bcl-2 and EGFR in ACHN and 786-O cells. And also induces sestrin 2, activates AMPKα and inhibits activation of mTOR and downstream kinases
[1]
.
DIM-C-pPhOH decreases expression of β1-integrin protein and mRNA and β1-integrin-dependent responses in MCF7, MDA-MB-231, and SKBR3 cells and also inhibits migration of the latter two cell lines
[2]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Proliferation Assay [1]
Cell Line: | ACHN and 786-O cells |
Concentration: | 7.5 μM, 15 μM, 20 μM |
Incubation Time: | 24 hours |
Result: | Significantly decreased cell proliferation. |
Apoptosis Analysis [1]
Cell Line: | ACHN and 786-O cells |
Concentration: | 20 μM |
Incubation Time: | 24 hours |
Result: | Induced apoptosis in ACHN and 786-O cells. |
Western Blot Analysis [1]
Cell Line: | ACHN and 786-O cells |
Concentration: | 15 μM, 20 μM |
Incubation Time: | 24 hours |
Result: | Inhibited NR4A1-regulated expression of survivin, bcl-2 and EGFR in ACHN and 786-O cells. And also induced sestrin 2, activated AMPKα and inhibited activation of mTOR and downstream kinases. |
DIM-C-pPhOH (30 mg/kg; oral gavage; daily; for 50 days; male athymic nude mice) treatment results in a significant inhibition of tumor growth [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | Male athymic nude mice (aged 6-7 weeks) injected with ACHN cells [1] |
Dosage: | 30 mg/kg/day |
Administration: | Oral gavage; daily; for 50 days |
Result: | Resulted in a significant inhibition of tumor growth. |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 125 mg/mL ( 369.39 mM ; ultrasonic and warming and heat to 60°C)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.9551 mL | 14.7754 mL | 29.5508 mL |
5 mM | 0.5910 mL | 2.9551 mL | 5.9102 mL |
10 mM | 0.2955 mL | 1.4775 mL | 2.9551 mL |